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OBJECTIVES: Intestinal neovascularization and abnormal abdominal arterial flow rates have been reported in
Crohn’s disease. The aim of this study was to evaluate Doppler sonography as a method for assessing Crohn’s
disease activity based on changes in splanchnic hemodynamics.
METHODS: Forty-eight patients with Crohn’s disease, 22 healthy volunteers and 12 patients with irritable bowel
syndrome were evaluated by Doppler ultrasound for flow parameters of the aorta and superior mesenteric
artery. This evaluation included the cross-sectional area, maximum flow volume, peak systolic velocity, end
diastolic velocity, resistance and the pulsatility index. Disease activity was classified according to the Crohn’s
disease activity index.
RESULTS: Most measurements in the aorta and superior mesenteric artery were significantly different between
Crohn’s disease patients and both control groups. Only the aortic maximum flow volume (CC = 0.37, p= 0.009)
and aortic peak systolic velocity (CC = 0.30, p= 0.035) showed a significant positive correlation with the Crohn’s
disease activity index. The determination of cut-off points for the aortic maximum flow volume and peak
systolic velocity measurements increased the sensitivity (80 and 75% for flow volume and velocity, respectively),
specificity (57 and 75%), accuracy (67 and 75%) and positive (57 and 68%) and negative (80 and 81%) predictive
values. These cut-off values permitted the correct classification of most of the patients with Crohn’s disease
with respect to disease activity. None of the superior mesenteric artery measurements were able to discriminate
patients in relation to disease activity.
CONCLUSION: The aortic maximum flow volume and peak systolic velocity levels estimated by Doppler
sonography reflected disease activity in Crohn’s disease. Doppler sonography of the aorta is therefore a novel
noninvasive adjunct method that may be useful in the clinical follow-up of patients with Crohn’s disease.
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& INTRODUCTION
Crohn’s disease (CD) is characterized by recurrent
inflammation of the gastrointestinal tract with inappropriate
or delayed healing, and it affects genetically susceptible
individuals who are exposed to environmental risk factors
(1). Although great advances have been made recently in the
understanding of CD etiopathogenesis (2,3), the medical
management of CD continues to be challenging. The
objective assessment of disease activity and response to
therapy has become progressively more critical for indivi-
dualized and optimized care, as the decision of whether and
when to initiate novel therapies may alter the natural course
of CD (4).
Serial assessment of CD activity is regarded as a
fundamental tool in the follow-up of patients and allows
the identification of specific conditions that may influence
clinical decisions. Several methods have been used to
investigate CD activity, but there is no consensus reference
method (5,6). Even the Crohn’s disease activity index
(CDAI), which is the most used and cited reference method,
has limitations because of the subjectivity of some of its
criteria (7). Endoscopic methods are commonly used for the
diagnosis and follow-up of CD patients; however, these
methods are invasive, expose patients to some potential
risks, usually require hospitalization, are expensive and still
have some limitations depending on the disease location (8).
Therefore, a new alternative method should be simple,
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reproducible and noninvasive to monitor disease activity
and response to therapy in CD; such a new method could
become an invaluable adjunct to clinical practice.
Recent advances in vascular biology have defined a key
role for the microcirculation in both the initiation and
perpetuation of inflammatory bowel diseases (IBD), includ-
ing CD. In particular, angiogenesis has been detected in
surgical samples of both the small and large bowel affected
by CD (9). In addition to histopathologic changes, CD is also
accompanied by remarkable changes in the splanchnic
circulation, as demonstrated by imaging studies (10,11).
Doppler sonography allows the assessment of the
splanchnic circulation and permits the measurement of
various parameters in the mesenteric arterial and venous
vasculature. In recent years, several studies with Doppler
sonography have been conducted to evaluate splanchnic
hemodynamics in CD (12-14). As an adjunct for CD
evaluation, preliminary Doppler sonography studies have
focused on the potential relationship between disease
activity and intestinal blood flow data, typically using flow
parameters of the superior mesenteric artery (SMA).
However, these studies have produced conflicting results
(15-21).
The aim of this prospective study was to evaluate the
potential application of Doppler sonography of the abdom-
inal aorta and SMA as a method for assessing CD disease
activity.
& PATIENTS AND METHODS
The study protocol was approved by the Ethical
Committee of the University Hospital of Federal
University of Rio de Janeiro and was therefore performed
in accordance with the ethical standards described in the
1964 Declaration of Helsinki. All subjects gave their
informed consent prior to inclusion in the study.
Study population
Forty-eight consecutive patients with Crohn’s disease
(CD) involving the ileum and/or the right colon were
enrolled in this study. Clinical diagnosis of CD was
confirmed by the combination of radiological, endoscopic
and histological criteria. Twelve patients with irritable
bowel syndrome (IBS) comprised the control group. A third
group composed of 22 healthy individuals, matched for age
and gender, was included for comparative analysis.
The patients with CD consisted of 28 females and 20
males, with a mean age of 38 years (range: 18-57 years).
According to the Montreal Classification (22), most (80.5%)
CD patients are diagnosed before the age of 40 years. The
classification of disease activity was determined by a
combination of a history, physical examination, laboratory
investigation, colonoscopy, barium study and Crohn’s
disease activity index (CDAI) for each patient (23). The
disease was categorized as active if the CDAI was $150 and
inactive if the CDAI was,150. The mean value observed for
disease activity was 102.9 (range 16-264). Twenty-four
subjects were in remission at the time of the study, whereas
the other 24 had moderately to severely active CD (score of
$150); none of the patients had a CDAI score above 450.
To establish the most homogeneous CD group and to
minimize potential confounding physical factors, only
patients with ileum and/or right colon involvement were
selected for analysis; patients with any history of prior
extensive surgery involving the small bowel or colon
(extensive ileal resection with ileo-transverse-anastomosis
and right hemicolectomy) were excluded from this study.
The disease location was ileocolonic in 55.3% of the patients,
restricted to the right colon in 27.9% and exclusively in the
terminal ileum in 16.8%. Regarding disease behavior, the
prevalence of predominantly penetrating, stricturing and
nonpenetrating nonstricturing forms was 39.6%, 35.4% and
25.0%, respectively. Twelve patients were taking prednisone
(10-40 mg/day) in combination with other medications,
whereas three patients were taking prednisone only.
Seventeen patients were using mesalamine (2-4 g/day)
alone or in combination with another group of drugs, and
ten patients were taking azathioprine (2-2.5 mg/kg/day).
Among the patients with CD, a previous history of intestinal
resection was present in 37.5% of the patients with active
disease and in 25% of the patients in remission.
The control group consisted of 22 healthy volunteers, with
15 females and 7 males and a median age of 33 years (20-55
years). An additional control group comprised patients with
IBS, with 10 females and 2 males and a median age of 46
years (range: 27-65 years). All of the patients presented with
chronic functional diarrhea, fulfilled the positive Rome III
criteria for IBS and had normal colonoscopies and no
histological abnormalities.
Regarding the mean age of the study groups, no
significant difference was found between CD patients and
the controls (p= 0.885) or IBS (p= 0.159) patients or between
the controls and IBS patients (p= 0.091).
Study Protocol
This cross-sectional study was conducted at a tertiary care
setting (University Hospital of the Federal University of Rio
de Janeiro) between April 2004 and December 2009. The
study population was representative of patients undergoing
regular follow-up in the gastroenterology outpatient unit. All
of the patients were clinically evaluated and received a CDAI
score during the same week of the Doppler measurements.
The extent of disease was evaluated using a barium enema
and/or colonoscopy. Exclusion criteria were age over 65
years and under 18 years, tobacco smoking, and any chronic
disease that could have significant hemodynamic effects,
such as advanced renal disease, vascular disease, cardiac
failure and cor pulmonale. None of the subjects in the study
were taking any cardiovascular medications, such as alpha-
or beta-blocking agents, calcium-channel blockers, angioten-
sin-converting enzyme inhibitors, angiotensin II receptor
antagonists, alpha-2 agonists, hydralazine or nitrates.
Doppler measurements
Color Doppler and gray-scale sonography analyses of the
aorta and the superior mesenteric artery (SMA) were
performed in all participants involved in this study. Color
Doppler sonography was performed using a Philips HDI-
3000 ultrasound system with a 3.75 MHz B-mode convex
transducer (Andover, Massachusetts, USA). The color
Doppler analysis was initiated 15 minutes after rest, in the
supine position and following a 12 hour fast to minimize the
influence of exercise, postural changes and meals on
hemodynamic variables. The same investigator, who was
unaware of the clinical status of the patients, examined all of
the subjects in the study.
The aorta and the SMA were studied in real time, and the
cross-sectional area was calculated during diastole. The
Aortic flow parameters in Crohn’s disease
Andrade TG et al.
CLINICS 2013;68(4):457-462
458
arteries were then examined in the long axis using an
insonation angle of less than 60 degrees. For the aortic
measurements, the parameters were acquired after the SMA
emergence.
The following parameters were measured: cross-sectional
area (cm2), peak systolic velocity (cm/s), end diastolic
velocity (cm/s) and resistive index. Each parameter was
recorded three times from three different cardiac cycles and
averaged for each patient to minimize random error. The
flow volume (ml/min), pulsatility index and mean velocity
(cm/s) were automatically calculated from digitized spec-
tral velocity waveform envelopes stored on a computer and
analyzed using HDI Laboratory software [ATL (Advanced
Technologies Laboratories); Philips Ultrasound].
Statistical Analysis
Statistical analyses were performed using the statistical
software SPSS for Windows (Version 10.1, SPSS Inc., 1989-
1999, USA). Significant differences among the experimental
groups were evaluated using the non-parametric Kruskal-
Wallis ANOVA ranks test, whereas the Mann-Whitney test
was applied for pairwise comparisons. Correlations
between sonographic measurements and the CDAI were
assessed using the Spearman rank correlation coefficient.
Values were expressed as medians with 95% confidence
intervals. Selected sonographic parameter-related sensitiv-
ities and specificities with positive and negative predictive
values and overall accuracy rates for CD activity were
calculated. The level of significance was set at p,0.05.
& RESULTS
Doppler measurements and potential clinical utility
for CD
Doppler sonography measurements were successfully
obtained from all individuals referred to the study. The
sonographic parameters described were calculated for each
of the 82 subjects examined. The median values (with 95%
confidence intervals) for each Doppler measurement in the
CD group, healthy volunteers and IBS group are summar-
ized in Table 1. Most measurements in the aorta and in the
superior mesenteric artery were significantly different
among the three groups. For the aortic measurements, the
cross-sectional area (CSA), maximum flow volume (Q), end
diastolic velocity (EDV) and pulsatility index (PI) were
significantly lower, whereas the resistive index (RI) was
higher in the CD patients than in both control groups
(Table 1). For the SMA measurements, the maximum flow
volume (Q), peak systolic velocity (PSV) and the end
diastolic velocity (EDV) were higher in the CD patients
than in the control groups (Table 1). No significant
difference was detected between healthy volunteers and
IBS patients (data not shown).
Doppler measurements and assessment of CD
activity
To determine Doppler sonographic parameters for the
assessment of Crohn’s disease activity, the relationship
between the measurements obtained for CD patients and
the CDAI scores was analyzed. Significant correlations were
found between the CDAI and aortic maximum flow volume
(Q) (CC=0.374, p= 0.009) and aortic peak systolic velocity
(PSV) (CC=0.305, p=0.035). Of all the parameters analyzed,
only the aortic Q and aortic PSV were significantly different,
with lower values in the active CD patients than in the
inactive CD patients (Tables 2 and 3). Of note, none of the
patients in the active group scored higher than 317.
Next, we analyzed the two variables in the aorta to
distinguish between active and inactive CD and also
determined cut-off points for stratification of patients.
Table 1 - Doppler sonography evaluation of the abdominal aorta and superior mesenteric artery of patients with CD,
healthy volunteers and IBS patients.
CD Control IBS p valuea
Abdominal aorta
Aortic CSA (cm2) 1.75 (0.92-3.27) 2.15 (1.20-5.30) 2.62 (1.10-4.05) 0.021
Aortic Q (mL/min) 3093 (1416-8638) 4558 (2126-11285) 4130 (2128-9125) 0.017
Aortic PSV (cm/s) 77.5 (45.3-167.4) 79.4 (50.7-152.9) 80.9 (38.9-104.1) 0.918
Aortic EDV (cm/s) 2.8 (0-33.6) 14.2 (0-39.4) 8.4 (0-26.3) 0.010
Aortic RI 0.95 (0.73-1.14) 0.80 (0.72-1.0) 0.89 (0.72-1.0) 0.010
Aortic PI 2.5 (1.4-3.0) 1.7 (1.4-3.0) 2.1 (1.4-3.0) 0.015
Superior m. artery
SMA CSA (cm2) 0.35 (0.17-0.73) 0.33 (0.20-0.67) 0.27 (0.14-0.55) 0.097
SMA Q (mL/min) 1905 (846-6770) 1334 (510-5296) 1166 (485-2972) 0.006
SMA PSV (cm/s) 202.3 (77.4-365.6) 151.2 (77.3-247.2) 145.4 (99.7-298.4) 0.008
SMA EDV (cm/s) 33.8 (9.1-97.2) 24.1 (11.4-55.4) 24.0 (15.5-64.2) 0.008
SMA RI 0.81 (0.67-0.94) 0.84 (0.67-0.94) 0.85 (0.78-0.89) 0.089
SMA PI 1.76 (1.20-2.53) 1.88 (1.22-2.50) 1.91 (1.64-2.18) 0.139
CD, Crohn’s disease; IBS, irritable bowel syndrome; SMA, superior mesenteric artery; CSA, cross-sectional area; Q, maximum flow volume; PSV, peak
systolic velocity; EDV, end diastolic velocity; RI, resistive index; PI, pulsatility index. The values presented are the medians with 95% confidence intervals.
aKruskal-Wallis H test.
Table 2 - Doppler sonography evaluation of the
abdominal aorta of patients with active and quiescent
Crohn’s disease based on the CDAI.
Active CD Quiescent CD p valuea
Aortic CSA (cm2) 1.55 (1.00-3.30) 1.90 (0.90-3.20) 0.166
Aortic Q (mL/min) 2685 (1362-6182) 3751 (1733-9095) 0.010
Aortic PSV (cm/s) 69.4 (54.2-143.4) 90.7 (45.2-169.5) 0.036
Aortic EDV (cm/s) 1.70 (0-16.1) 3.95 (0-35.9) 0.394
Aortic RI 0.99 (0.77-1.20) 0.90 (0.73-1.00) 0.155
Aortic PI 2.85 (1.60-3.00) 2.35 (1.40-3.00) 0.314
CD, Crohn’s disease; CSA, cross-sectional area; Q, maximum flow volume;
PSV, peak systolic velocity; EDV, end diastolic velocity; RI, resistive index;
PI, pulsatility index. The values presented are medians with 95%
confidence intervals. aMann-Whitney test.
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Arbitrary cut-off values of aortic Q,4500 mL/min and an
aortic PSV,70 cm/s were chosen so that the maximum
possible number of CD patients was correctly classified
according to disease activity. The overall sensitivity,
specificity, accuracy, positive predictive value and negative
predictive value were calculated for both parameters (Table
4).
& DISCUSSION
In the current study, we demonstrated the technical
feasibility and potential clinical utility of Doppler sonogra-
phy for patients with CD. The sonographic parameters
analyzed showed that most measurements in the aorta and
in the superior mesenteric artery were significantly different
in the CD patients relative to either healthy subjects or
patients with IBS. For assessment of disease activity, only
the aortic measurements of maximum flow volume and
aortic peak systolic velocity were significantly correlated
with CDAI, with lower values in active CD. In addition,
after selecting these two parameters, we determined cut-off
points to accurately classify patients with regard to disease
activity. The results indicate that the stratification of aortic
maximum flow volume and peak systolic velocity values
allowed a simple and accurate distinction to be made
between active and inactive CD patients.
Despite advances in clinical techniques, the optimal
therapy for CD still depends on correct classification of
disease activity. Although substantial efforts have been
made to develop new methods for evaluating CD activity,
the CDAI is still the most widely used method in clinical
trials and in routine practice, including the analysis of the
response to treatment. In the last decade, abdominal
Doppler ultrasound has been presented as a potential
alternative for the evaluation of CD activity and is
predominantly based on measurements obtained in the
SMA. In addition, neovascularization and hyperemia of
inflamed areas of the gut have also been investigated with
the use of color Doppler and power Doppler (24,25) as well
as pulsed Doppler spectral analysis (26,27). In this study, in
addition to comparing SMA measurements with data from
previous studies, we demonstrated for the first time the
simultaneous acquisition of SMA and abdominal aorta
measurements.
We demonstrated in this study that most of the
parameters analyzed by Doppler ultrasound examination
were significantly different between patients with CD and
control individuals. Overall, our data appear to agree with
previous studies that also detected differences in splanchnic
hemodynamics in CD (14,28-30). Furthermore, the opposing
results for the aortic and SMA parameters in the same
individuals support the presence of different levels of
macrovascular control in the splanchnic circulation and
possibly the existence of pathologic compensatory mechan-
isms in CD hemodynamics. Although Doppler sonography
is not required for the diagnosis of CD and is not being
proposed as a new diagnostic tool, the results presented
here support the general hypothesis that vascular abnorm-
alities are constitutive elements in the pathogenesis of CD
(31,32).
With regard to CD activity, prior studies on Doppler
sonography have presented conflicting results. In a recent
study, Doppler sonography for the evaluation of the SMA
by segments in gray scale was presented as an excellent
method for assessing CD activity (33). Other studies on the
analysis of specific SMA measurements have suggested that
either the resistance index (17,18) or the maximum flow
volume (13,29) is the best parameter for differentiating CD
patients. In contrast, a similar study failed to correlate the
hyperdynamic mesenteric circulation detected in CD
patients with the clinical or biochemical activity of the
disease (14). In agreement with these results, our Doppler
measurements obtained in the SMA confirmed the presence
of hyperdynamic circulation in CD; however, these mea-
surements could not distinguish disease activity among
patients. In contrast, the significant differences in aortic
measurements were correlated with disease activity. The
most accurate Doppler parameter for the evaluation of CD
activity was the estimated intensity of the maximum flow
volume and peak systolic velocity; both of these parameters
were shown to be lower in active CD.
Previous studies questioned the reliability of results
obtained by Doppler sonography of small size vessels for
the evaluation of CD activity (15,17). Similarly, we present
superior results from the aorta relative to the SMA; this
difference is likely associated with the dimensions and
particularly the diameter of the vessels involved. Previous
major abdominal surgeries could also impose technical
difficulties and affect the overall quality of results (28). To
minimize this potentially confounding factor in our study,
we only examined patients who had never been submitted
to any abdominal surgery and patients who underwent only
Table 3 - Doppler sonography evaluation of the superior
mesenteric artery of patients with active and quiescent
Crohn’s disease based on the CDAI.
Active CD Quiescent CD p valuea
SMA CSA (cm2) 0.33 (0.20-0.61) 0.38 (0.16-0.74) 0.228
SMA Q (mL/min) 1620 (871-3609) 2093 (840-6833) 0.322
SMA PSV (cm/s) 203.0 (75.1-366.3) 200.5 (85.7-355.7) 0.818
SMA EDV (cm/s) 30.75 (7.60-94.6) 37.0 (14.3-98.0) 0.433
SMA RI 0.82 (0.67-0.95) 0.78 (0.67-0.93) 0.285
SMA PI 1.81 (1.20-2.56) 1.65 (1.22-2.41) 0.774
CD, Crohn’s disease; SMA, superior mesenteric artery; CSA, cross-sectional
area; Q, maximum flow volume; PSV, peak systolic velocity; EDV, end
diastolic velocity; RI, resistive index; PI, pulsatility index. The values
presented are medians with 95% confidence intervals. aMann-Whitney
test.
Table 4 - Critical analysis of selected Doppler sonography parameters for detecting active Crohn’s disease based on the
CDAI.
Variable (s) Sensitivity Specificity Accuracy Positive Predictive Value Negative Predictive Value
Aortic Q , 4500 mL/min 16 of 20 (80) 16 of 28 (57) 32 of 48 (67) 16 of 28 (57) 16 of 20 (80)
Aortic PSV , 70 cm/s 15 of 20 (75) 21 of 28 (75) 36 of 48 (75) 15 of 22 (68) 21 of 26 (81)
Q, maximum flow volume; PSV, peak systolic velocity. The values presented are the number of findings with percentages in parentheses.
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minor surgical procedures, such as an inguinal hernia
repair, cholecystectomy or appendectomy.
Of note, this study inadvertently selected consecutive CD
patients with a relatively low intensity of disease based on
the CDAI. In contrast to most studies where patients with a
CDAI.450 have been categorized as having a high degree
of activity, we only analyzed patients with a CDAI between
9 and 317. This factor may explain some differences between
our results and those of other studies, especially concerning
the SMA measurements. Moreover, the narrow range of
disease activity may not have allowed a clear discrimination
among the CD subjects enrolled in this study. Therefore,
further studies with a higher number of both patients and
control subjects are necessary to confirm the findings and
the utility of Doppler sonography as an adjunctive tool for
the evaluation of CD.
In conclusion, as a feasible and accurate technique,
Doppler sonography of the aorta is a novel noninvasive
adjunct method that may be useful in the clinical follow-up
of patients with CD.
& ACKNOWLEDGMENTS
The authors wish to thank the Brazilian research foundations CNPq and
FAPERJ for financial support. The authors are grateful to the medical staff
of the Gastroenterology Division of the University Hospital for their
assistance with patient selection. The authors are also grateful to the D’Or
Laboratory for their support and for the opportunity to use their
equipment for this study.
& AUTHOR CONTRIBUTIONS
Andrade TG was involved with the study design, patient selection and
follow-up, data collection and interpretation and manuscript preparation.
Fogac¸a H was involved with the study design, ultra-sonographic
examinations, patient selection and critical review of the manuscript. Elia
C was involved with data interpretation, obtained funding and provided a
critical review of the manuscript. Pitrowsky M was involved with the
patient selection and follow-up, data collection and interpretation and
statistical analysis. Souza HS obtained funding and was involved with data
interpretation, statistical analysis, critical review of the manuscript and
manuscript writing.
& REFERENCES
1. Podolsky DK. Inflammatory bowel disease. N Engl J Med.
2002;347(6):417-29.
2. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory
bowel disease. Nature. 2007;448(7152):427-34, http://dx.doi.org/10.
1038/nature06005.
3. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory
bowel disease. J Clin Invest. 2007;117(3):514-21, http://dx.doi.org/10.
1172/JCI30587.
4. D’Haens GR, Fedorak R, Le´mann M, Feagan BG, Kamm MA, Cosnes J,
et al. Endpoints for clinical trials evaluating disease modification and
structural damage in adults with Crohn’s disease. Inflamm Bowel Dis.
2009;15(10):1599-604, http://dx.doi.org/10.1002/ibd.21034.
5. Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Lo¨fberg R, Modigliani
R, et al. A review of activity indices and efficacy endpoints for clinical
trials of medical therapy in adults with Crohn’s disease.
Gastroenterology. 2002;122(2):512-30, http://dx.doi.org/10.1053/gast.
2002.31072.
6. Lichtenstein GR, Hanauer SB, Sandborn WJ. Practice Parameters
Committee of American College of Gastroenterology (2009).
Management of Crohn’s disease in adults. Am J Gastroenterol.
2009;104:465-83, http://dx.doi.org/10.1038/ajg.2008.168.
7. Freeman HJ. Use of the Crohn’s disease activity index in clinical trials of
biological agents. World J Gastroenterol. 2008;14(26):4127-130.
8. Terheggen G, Lanyi B, Schanz S, Hoffmann RM, Bo¨hm SK, Leifeld L, et al.
Safety, feasibility, and tolerability of ileocolonoscopy in inflammatory
bowel disease. Endoscopy. 2008;40(8):656-63, http://dx.doi.org/10.
1055/s-2008-1077445.
9. Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles PM, Lewis AA,
Pounder RE. Pathogenesis of Crohn’s disease: multifocal gastrointestinal
infarction. Lancet. 1989;2(8671):1057-62, http://dx.doi.org/10.1016/S0140-
6736(89)91078-7.
10. Lunderquist A, Knutsson H. Angiography in Crohn’s disease of the
small bowel and colon. Am J Roentgenol Radium Ther Nucl Med.
1967;101(2):338-44, http://dx.doi.org/10.2214/ajr.101.2.338.
11. Giaffer MH, Tindale WB, Senior S, Barber DC, Holdsworth CD.
Quantification of disease activity in Crohn’s disease by computer
analysis of Tc-99m hexamethyl propylene amine oxime (HMPAO)
labelled leucocyte images. Gut. 1993;34(1):68-74, http://dx.doi.org/10.
1136/gut.34.1.68.
12. Maconi G, Imbesi V, Bianchi Porro G. Doppler ultrasoundmeasurement of
intestinal blood flow inflammatory bowel disease. Scand J Gastroenterol.
1996;31(6):590-3.
13. ErdenA, Cumhur T,Olcer T. Superiormesenteric arteryDoppler waveform
changes in response to inflammation of the ileocecal region. Abdom
Imaging. 1997;22(5):483-6, http://dx.doi.org/10.1007/s002619900243.
14. Maconi G, Parente F, Bollani S, Imbesi V, Ardizzone S, Russo A, Bianchi
Porro G. Factors affecting splanchnic haemodynamics in Crohn’s
disease: a prospective controlled study using Doppler ultrasound. Gut.
1998;43(5):645-50, http://dx.doi.org/10.1136/gut.43.5.645.
15. Byrne MF, Farrell MA, Abass S, Fitzgerald A, Varghese JC, Thornton F,
et al. Assessment of Crohn’s disease activity by Doppler sonography of
the superior mesenteric artery, clinical evaluation and the Crohn’s
disease activity index: a prospective study. Clin Radiol. 2001;56(12):973-
8, http://dx.doi.org/10.1053/crad.2001.0794.
16. van Oostayen JA, Wasser MN, Griffioen G, van Hogezand RA, Lamers
CB, de Roos A. Activity of Crohn’s disease assessed by measurement of
superior mesenteric artery flow with Doppler ultrasound. Neth J Med.
1998;53(6):S3-8.
17. Bolondi L, Gaiani S, Brignola C, Campieri M, Rigamonti A, Zironi G, et al.
Changes in splanchnic hemodynamics in inflammatory bowel disease.
Non-invasive assessment by Doppler ultrasound flowmetry.
Scand J Gastroenterol. 1992;27(6):501-7.
18. Giovagnorio F, Diacinti D, Vernia P. Doppler sonography of the superior
mesenteric artery in Crohn’s disease. AJR Am J Roentgenol.
1998;170(1):123-6, http://dx.doi.org/10.2214/ajr.170.1.9423614.
19. Ludwig D, Wiener S, Bru¨ning A, Schwarting K, Jantschek G, Stange EF.
Mesenteric blood flow is related to disease activity and risk of relapse in
Crohn’s disease: a prospective follow-up study. Am J Gastroenterol.
1999;94(10):2942-50.
20. Ludwig D, Wiener S, Bru¨ning A, Schwarting K, Jantschek G, Fellermann
K, et al. Mesenteric blood flow is related to disease activity and risk of
relapse in ulcerative colitis: a prospective follow up study. Gut.
1999;45(4):546-52, http://dx.doi.org/10.1136/gut.45.4.546.
21. Dietrich CF, Jedrzejczyk M, Ignee A. Sonographic assessment of
splanchnic arteries and the bowel wall. Eur J Radiol. 2007;64(2):202-12.
22. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal
classification of inflammatory bowel disease: controversies, consensus,
and implications. Gut. 2006;55(6):749-53, http://dx.doi.org/10.1136/gut.
2005.082909.
23. Best WR, Becktel JM, Singleton JW. Rederived values of the eight
coefficients of the Crohn’s Disease Activity Index (CDAI).
Gastroenterology. 1979;77(4 Pt 2):843-6.
24. van Oostayen JA, Wasser MN, van Hogezand RA, Griffioen G, de Roos
A. Activity of Crohn disease assessed by measurement of superior
mesenteric artery flow with Doppler US. Radiology. 1994;193(2):551-4.
25. Heyne R, Rickes S, Bock P, Schreiber S, Wermke W, Lochs H. Non-
invasive evaluation of activity in inflammatory bowel disease by power
Doppler sonography. Zeitschrift fur Gastroenterologie. 2002;40(3):171-5,
http://dx.doi.org/10.1055/s-2002-22325.
26. Esteban JM, Maldonado L, Sanchiz V, Minguez M, Benages A. Activity of
Crohn’s disease assessed by colour Doppler ultrasound analysis of the
affected loops. Eur Radiol. 2001;11(8):1423-8.
27. Sjekavica I, Barbaric´-Babic´ V, Krznaric´ Z, Molnar M, Cukovic´-Cavka S,
Stern-Padovan R. Assessment of Crohn’s disease activity by doppler
ultrasound of superior mesenteric artery and mural arteries in thickened
bowel wall: cross-sectional study. Croat Med J. 2007;48(6):822-30, http://
dx.doi.org/10.3325/cmj.2007.6.822.
28. van Oostayen JA, Wasser MN, van Hogezand RA, Griffioen G, Biemond
I, Lamers CB, et al. Doppler sonography evaluation of superior
mesenteric artery flow to assess Crohn’s disease activity: correlation
with clinical evaluation, Crohn’s disease activity index, and alpha 1-
antitrypsin clearance in feces. AJR Am J Roentgenol. 1997;168(2):429-33,
http://dx.doi.org/10.2214/ajr.168.2.9016220.
29. van Oostayen JA, Wasser MN, Griffioen G, van Hogezand RA, Lamers
CB, de Roos A. Diagnosis of Crohn’s ileitis and monitoring of disease
activity: value of Doppler ultrasound of superior mesenteric artery flow.
Am J Gastroenterol. 1998;93(1):88-91.
30. Ludwig D. Doppler sonography in inflammatory bowel disease.
Z Gastroenterol. 2004;42(9):1059-65, http://dx.doi.org/10.1055/s-2004-
813308.
31. Thornton M, Solomon MJ. Crohn’s disease: in defense of a microvascular
aetiology. Int J Colorectal Dis. 2002;17(5):287-97, http://dx.doi.org/10.
1007/s00384-002-0408-5.
CLINICS 2013;68(4):457-462 Aortic flow parameters in Crohn’s disease
Andrade TG et al.
461
32. Hatoum OA, Binion DG, Otterson MF, Gutterman DD. Acquired
microvascular dysfunction in inflammatory bowel disease: loss of nitric
oxide-mediated vasodilation. Gastroenterol. 2003;125(1):58-69, http://
dx.doi.org/10.1016/S0016-5085(03)00699-1.
33. Yekeler E, Danalioglu A, Movasseghi B, Yilmaz S, Karaca C,
Kaymakoglu S, et al. Crohn disease activity evaluated by Doppler
ultrasonography of the superior mesenteric artery and the affected small-
bowel segments. J Ultrasound Med. 2005;24(1):59-65.
Aortic flow parameters in Crohn’s disease
Andrade TG et al.
CLINICS 2013;68(4):457-462
462
